Video Buzz v1
Highlighting streaming videos you should be watching
RelatedLinks
July 4th
- RNA Snippet Suppresses Spread Of Aggressive Breast Cancer
- Medical Updates - ?Trojan Horse? Used to Terminate Cancer Cells | Health News
July 2nd
June 22nd
June 21st
June 19th
- RNAi Transfection Resource: Transfection blog: pre-optimized RNAi transfection protocols and products. Transfection methods and techniques.
- Cells Transfection Products :: Altogen Biosystems: Altogen Biosystems develops and commercializes pre-optimized transfection kits for 70+ cell lines and primary cells. Transfection reagents are highly efficient for plasmid DNA and siRNA transfection in vitro and in vivo.
June 18th
June 17th
June 15th
- hKSR-2, a vitamin D?regulated gene, inhibits apoptosis in arabinocytosin e-treated HL60 leukemia cells ? Mol Cancer Ther: KSR
- Pre-designed siRNA Reagents
June 11th
- ScienceDirect - Cell : A Pleiotropicall y Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
- ScienceDirect - Cell : New Hope for a MicroRNA Therapy for Liver Cancer
- WI siRNA Selection Program
June 8th
- Robust statistical methods for hit selection in RNA interference high-throughpu t screening experiments: DOI 10.2217/146224 16.7.3.299
RelatedImages
Video Buzz > RNAi
No Matching Video
No video for RNAi is available at this time.
Related RNAi News
Biting hands that feed - Boston Globe
Biotech companies fight with each other over the commercial rights to ideas and technology all the time. Patent lawsuits are as much a part of the business as lab work and clinical trials. But those companies rarely go to court against big ...
Alnylam Joins Max Planck in Legal Action toward Whitehead Institute - Phramalive.com
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 26, 2009 - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has joined with the Max Planck Society in taking legal action toward the Whitehead Institute ...
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial - Phramalive.com
VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 2, 2009) - Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP. ApoB SNALP, Tekmira's lead RNAi therapeutic product ...
Government funding a possibility, says Genesis R&D - National Business Review
Genesis Research & Development is planning to raise capital and says government funding is ?a possibility? to help secure its future. In a presentation to investors yesterday Genesis said it had just $300,000 left in the kitty and was in ...
Microtubules Might Be Responsible For Some Cases Of The Neurological ... - Science Daily
ScienceDaily (June 29, 2009) ? Stalled microtubules might be responsible for some cases of the neurological disorder Charcot-Marie-Tooth (CMT) disease, Tanabe and Takei report in the June 15, 2009 issue of the Journal of Cell Biology. A mutant ...
RNAi Podcasts
Do you prefer to listen to your rnai gossip? Check out Podzy Podcast Directory > RNAi.
RNAi Products
Looking for rnai related products, then look no further. Try our new RNAi Shop.